Third Scientific Conference and sixth EMARIS meeting on acute respiratory infections in the ...
18 March 2023 – Focusing on better preparedness, early detection, rapid response, and enhanced research for respiratory diseases, the Third Scientific Conference and the sixth EMARIS meeting on acute respiratory infections in the Eastern Mediterranean Region concluded in Muscat, Oman.
Serving as a platform to showcase partnership and solidarity, the 3-day meeting and conference convened more than 200 health experts from WHO, Member States, US Centers for Disease Control and Prevention and partner organizations.
Besides extensive deliberations, the recommendations of the meeting and conference focused o...
Source: WHO EMRO News - March 19, 2023 Category: Middle East Health Source Type: news
SARS-CoV-2 and Influenza Coinfection Among Those < 18 Years SARS-CoV-2 and Influenza Coinfection Among Those < 18 Years
Most pediatric patients coninfected with COVID-19 and influenza who were hospitalized or died had underlying medical conditions and were not fully vaccinated against flu, according to this report.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 10, 2023 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news
U.S. Considers Vaccinating Chickens Amid Bird Flu Outbreak
The largest outbreak of avian influenza in U.S. history has driven up egg prices and raised concerns about a human pandemic, though C.D.C. experts say the risk of that is low. (Source: NYT Health)
Source: NYT Health - March 6, 2023 Category: Consumer Health News Authors: Sheryl Gay Stolberg and Emily Anthes Tags: Avian Influenza Chickens Vaccination and Immunization Agriculture and Farming Agriculture Department International Trade and World Market Birds Poultry Eggs Biden, Joseph R Jr United States Politics and Government Source Type: news
Late-Breaking Phase 3 A DUE Data Show Investigational Single Tablet Combination Therapy of Macitentan and Tadalafil Significantly Improves Pulmonary Hemodynamics versus Monotherapy in Patients with Pulmonary Arterial Hypertension (PAH)
RARITAN, NJ, March 6, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the Phase 3 A DUE study (NCT03904693), which showed an investigational once-daily, single tablet combination therapy, also known as fixed dose combination, of macitentan 10 mg and tadalafil 40 mg (M/T STCT), significantly improved pulmonary hemodynamics (blood flow through pulmonary blood vessels) versus macitentan and tadalafil monotherapies in pulmonary arterial hypertension (PAH) patients with World Health Organization (WHO) functional class (FC) II or III.[1] The data were presented today as a Late-...
Source: Johnson and Johnson - March 6, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
FDA Panel Backs GSK ’s RSV Vaccine for Older People
GSK Plc’s vaccine for respiratory syncytial virus won the support of a key panel of U.S. regulatory advisers for use in people aged 60 and older, as the drugmaker races against Pfizer Inc. to bring to market the first vaccine for RSV.
The panel of 12 outside advisers to the Food and Drug Administration voted unanimously on Wednesday that GSK’s data show the Arexvy vaccine is effective. The same committee voted 10-2 that company data show the shot is safe. By contrast, it had voted 7-4 with one abstention to recommend Pfizer’s vaccine as both safe and effective in preventing RSV.
[time-brightcove not-tgx=&...
Source: TIME: Health - March 2, 2023 Category: Consumer Health News Authors: Lisa Pham and Tanaz Meghjani/Bloomberg Tags: Uncategorized bloomberg wire Drugs healthscienceclimate News Source Type: news
Flu Vaccine Effective for 2022/2023 Season
MONDAY, Feb. 27, 2023 -- During the 2022 to 2023 influenza season, vaccination is effective for reducing the risk for medically attended influenza among children and adults aged younger than 65 years and for symptomatic influenza among children,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 27, 2023 Category: Pharmaceuticals Source Type: news
Computer model of influenza virus shows universal vaccine promise
Each year there are an estimated 1 billion cases of influenza, including 3-5 million severe cases and up to 650,000 influenza-related respiratory deaths globally, according to the World Health Organization. Seasonal flu vaccines must be reformulated … (Source: NSF News)
Source: NSF News - February 27, 2023 Category: Science Authors: NSF Source Type: news
FDA approves first at-home test to detect both flu and COVID
People will soon be able to self-test for both flu and COVID-19 in one fell swoop — without leaving their homes. The Food and Drug Administration (FDA) has authorized the first over-the-counter (OTC) home test that can detect both influenza A and B as well as SARS-CoV-2, the virus that causes…#fda #jeffshuren #jd #holidays #didnthappen #sayscdc #vaccines #georgethompson #sacramento #foxnewsdigital (Source: Reuters: Health)
Source: Reuters: Health - February 25, 2023 Category: Consumer Health News Source Type: news
Flu Shots Have Been Working Well This Season, Data Suggest
The influenza vaccine has worked fairly well this season, preventing serious flu cases and hospitalizations across age groups, according to preliminary data released by the U.S. Centers for Disease Control and Prevention (CDC).
Flu shot efficacy varies from year to year, since different strains of the virus circulate each flu season. Experts do their best to tailor the shots to the strains expected to spread, but it’s not always a perfect fit. In some years, flu shot efficacy doesn’t break 30%.
So far, however, this season’s flu shots have been 71% effective at preventing symptomatic illness among childre...
Source: TIME: Health - February 23, 2023 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate medicine Source Type: news
Interim Estimates of 2022-23 Seasonal Influenza Vaccine Effectiveness - Wisconsin, October 2022-February 2023
This report describes 54% effectiveness for the 2023-23 influenza vaccine for preventing medically attended influenza A infection in people older than 65 years. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - February 23, 2023 Category: American Health Tags: Influenza (Flu) Influenza Vaccination MMWR Morbidity & Mortality Weekly Report Source Type: news
Text Message Reminders About Kids' Flu Vaccines Prove Successful
(MedPage Today) -- An additional text message reminder to parents of children with special-risk medical conditions led to an increase in influenza vaccine uptake compared with reminders from clinicians alone, a randomized trial from Australia showed... (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - February 20, 2023 Category: Pediatrics Source Type: news
Coronavirus tally: Moderna flu vaccine trial falls short on one goal, sending stock down
Moderna Inc. MRNA, stock was down 6.6% premarket Friday, after the COVID vaccine maker said a trial of a flu vaccine candidate failed to meet one of its goals. "While we did not achieve non-inferiority for the Influenza B strains which are more frequent in younger populations, we have already…#modernaincmrna #stephenhoge (Source: Reuters: Health)
Source: Reuters: Health - February 17, 2023 Category: Consumer Health News Source Type: news
Two Vaccines May Soon Shield Seniors Against RSV
THURSDAY, Feb. 16, 2023 -- Older people have vaccines available to prevent severe influenza and COVID-19, but there ’s been nothing to protect against the third respiratory virus that contributed to this season’s wretched... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 16, 2023 Category: General Medicine Source Type: news
Codagenix Announces Close of $25 million Extension of Series B
Funding supports continued clinical studies for pediatric RSV and universal influenza vaccine candidates as well as expanded indications for oncology vertical
FARMINGDALE, N.Y. and CAMBRIDGE, Mass., Feb. 15, 2023 -- (Healthcare Sales & Marketing Network... Biopharmaceuticals, Venture Capital Codagenix, CodaVax-RSV, respiratory syncytial virus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 15, 2023 Category: Pharmaceuticals Source Type: news
U.S. to Test Vaccines in Poultry as Way to Curb Bird Flu Outbreak
FRIDAY, Feb. 10, 2023 -- U.S. health officials are considering using vaccines in poultry to stem an ongoing outbreak of bird flu. Scientists will begin testing the first vaccines for birds in years as the spread of avian influenza has killed about... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 10, 2023 Category: Pharmaceuticals Source Type: news
